LIGAND PHARMACEUTICALS INCORPORATED Stock Repurchased During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for the quarter ending 2025-09-30 was $15.00M.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for the quarter ending 2025-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for the quarter ending 2025-03-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for the quarter ending 2024-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for fiscal 2024 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for fiscal 2022 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED stock repurchased during period, value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Stock Repurchased During Period, Value 3 month | Stock Repurchased During Period, Value 12 month |
|---|---|---|
| 2025-09-30 | $15.00M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $78.00M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | $155.22M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 10-Q · filed 2020-11-06 | $336.41M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $73.29M 10-Q · filed 2021-11-09 | $370.13M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $81.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $448.43M 10-K · filed 2022-02-28 |
| 2019-09-30 | $181.19M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $33.72M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $151.59M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $127.48M 10-K · filed 2021-02-24 | |
| 2018-06-30 | $50.83M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $1.90M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $1.97M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $3.90M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $489.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $29.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $67.95M 10-K · filed 2017-02-28 |
| 2014-09-30 | $38.50M 10-Q · filed 2014-10-31 | |
| 2012-12-31 | $55.00K 10-K · filed 2014-12-01 | |
| 2011-12-31 | $55.00K 10-K/A · filed 2014-12-12 | |
| 2010-12-31 | $91.00K 10-K · filed 2013-03-14 |